SynthesisTargeted oncology2019

Comparative Efficacy of CDK4/6 Inhibitors Plus Aromatase Inhibitors Versus Fulvestrant for the First-Line Treatment of Hormone Receptor-Positive Advanced Breast Cancer: A Network Meta-Analysis.

Qianqian Guo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.